DNA Ginkgo Bioworks Holdings, Inc. Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
All Content
Source feeds
Buzzberg Top 50
All market capsNo capitalization filter
200 B and aboveMega
10 B to 200 BLarge
2 B to 10 BMid
0 to 2 BSmall
Custom
Enter market cap range in B USD
All directions
▲ Long
▼ Short
⛔ Avoid
✂ Close
◦ Others
Any score
LOW+
MED+
HIGH
? ?
14:33
Jun 04
Speaker notes price momentum in $DNA after previously cutting a long position; no current directional commitment.
DNA
LOW
14:17
Jun 03
Author exits DNA position for portfolio management reasons, not due to a change in thesis, so no forward directional call is made.
DNA
20:25
Jun 02
temple_eight AI Photonics Trader
Speaker expresses favorable view on $DNA but considers it premature; no trade commitment.
DNA
LOW
19:57
Jun 02
The author warns that the digital biology narrative will cause many biotechs to rerate without fundamental support, advising caution on picking the right names rather than taking a directional position.
DNA
19:24
Jun 02
Buy DNA speculatively on the Microsoft partnership and OpenAI collaboration, betting AI-driven biotech theme gains momentum.
DNA
MED
08:02
Mar 02
Noah Smith Economist; ex-columnist, Bloomberg Opinion Noahpinion
The article explicitly describes a collaboration between Google and Ginkgo Bioworks where GPT-5 connected to an autonomous lab reduced protein production cost by 40% and compressed 150 years of work i
The article explicitly describes a collaboration between Google and Ginkgo Bioworks where GPT-5 connected to an autonomous lab reduced protein production cost by 40% and compressed 150 years of work into weeks. This validates Ginkgo's platform-as-a-service model and signals growing commercial adoption of AI-driven synthetic biology. Risk: Partnership dependency on Google; Ginkgo's revenue still small and path to profitability uncertain.
DNA
20:34
Feb 09
Long $DNA — speaker explicitly states 'I've also begun a starter position in $DNA today' citing Ginkgo Bioworks' Autonomous Laboratory + OpenAI GPT-5 milestone achieving 40% improvement over state-of-the-art benchmark.
DNA 1ST
HIGH

About DNA Analyst Coverage

Buzzberg tracks DNA (Ginkgo Bioworks Holdings, Inc.) across 4 sources. 2 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (29%). 7 total trade ideas tracked. Latest voices: thematictrader, temple_eight, CryptoCondom.